# FDA 483 - Muhammad Y. Sheikh, M.D. - February 11, 2022

Source: https://www.globalkeysolutions.net/records/483/muhammad-y-sheikh-md/c5de9626-5921-44de-af3b-01c95467e389

> FDA 483 for Muhammad Y. Sheikh, M.D. on February 11, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Muhammad Y. Sheikh, M.D.
- Inspection Date: 2022-02-11
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West V
- Summary: An FDA inspection of Muhammad Y. Sheikh, M.D. in Fresno, CA, revealed that a clinical investigation was not conducted in accordance with the signed statement of investigator and investigational plan. The primary issue involved the randomization of multiple ineligible subjects into Protocol MGL-3196-14. These subjects failed to meet various exclusion or inclusion criteria, indicating significant deviations in study conduct and screening procedures.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/sandra-saniga/a1a89397-a095-46de-9355-aa1cd88d729a)

Company: https://www.globalkeysolutions.net/companies/muhammad-y-sheikh-md/7018b77a-f548-4366-9c54-096137ced842

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-v/0f4dd01e-8e8a-4336-9abe-ce8b3d309e8b